Scilex Holding (SCLXW) Current Assets (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Current Assets of $42.0 million in Q1 2026, up 9.42% quarter-over-quarter from $38.4 million in Q4 2025, and up 46.22% on a YoY basis from $28.7 million in Q1 2025.

Scilex Holding (SCLXW) Current Assets (2020 - 2026) Analysis & Trends

Scilex Holding's Current Assets history runs 7 years deep, the most recent figure standing at $42.0 million for Q1 2026.

  • In Q1 2026, Current Assets rose 46.22% year-over-year to $42.0 million; the TTM figure through Mar 2026 stood at $42.0 million (up 46.22% YoY), while the FY2025 annual figure was $38.4 million, down 7.68% from the prior year.
  • Current Assets was $42.0 million for Q1 2026 at Scilex Holding, up from $38.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $69.2 million in Q2 2023 to a low of $165749.0 in Q3 2022.
  • Historically, Current Assets has averaged $31.3 million across 5 years, with a median of $33.7 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Current Assets jumped 15273.25% in 2023, then slumped 58.63% in 2025.
  • A 5-year view of Current Assets shows it stood at $29.6 million in 2022, then surged by 58.0% to $46.8 million in 2023, then declined by 11.19% to $41.5 million in 2024, then retreated by 7.68% to $38.4 million in 2025, then advanced by 9.42% to $42.0 million in 2026.
  • The last three Current Assets figures came in at $42.0 million (Q1 2026), $38.4 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 23.94 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 54.84 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 59.17 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 33.53 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 35.02 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 31.48 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 18.64 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 42.82 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 27.21 Bn
10 Scilex Holding - - 4.15 Mn 41.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 41.97 Mn
Dec 31, 2025 38.36 Mn
Sep 30, 2025 16.49 Mn
Jun 30, 2025 33.67 Mn
Mar 31, 2025 28.70 Mn
Dec 31, 2024 41.55 Mn
Sep 30, 2024 39.86 Mn
Jun 30, 2024 50.42 Mn
Mar 31, 2024 37.75 Mn
Dec 31, 2023 46.78 Mn
Sep 30, 2023 25.48 Mn
Jun 30, 2023 69.25 Mn
Mar 31, 2023 31.10 Mn
Dec 31, 2022 29.61 Mn
Sep 30, 2022 165,749.00
Jun 30, 2022 612,848.00
Mar 31, 2022 524,341.00
Dec 31, 2021 23.00 Mn
Sep 30, 2021 232,178.00
Jun 30, 2021 491,980.00